Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) (the “Company”), the leader in Stock News Live Stock News Today Trending News AI news FDA Approvals. See ZYNE stock price and Buy/Sell Zynerba Pharmaceuticals. Discuss news and analysts' price predictions with the investor community. Start investing. ZYNE. Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) released its quarterly earnings data on Monday, May, 15th. The company reported ($) earnings per share (EPS) for. Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and. Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) stock rocketed three times higher News. on 12/21/ Zynerba Pharmaceuticals.
Zynerba Pharmaceuticals, Inc NASDAQ: ZYNE is focused in the pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric. Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for. The average price target for Zynerba Pharmaceuticals is $ This is based on 3 Wall Streets Analysts month price targets, issued in the past 3 months. Get the latest Zynerba Pharmaceuticals Inc. (ZYNE) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. You can watch ZYNE and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling. 14 Aug HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC. · Completion of FXS Phase 3 clinical trial: $15 million in the aggregate or. ZYNE Zynerba Pharmaceuticals, Inc. Stock Price & Overview ZYNE is defunct since October 12, LATEST NEWS FROM ZYNERBA PHARMACEUTICALS Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental. View ZYNERBA PHARMACEUTICALS INC COM CVR (gentleherd.ru) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Track Zynerba Pharmaceuticals Inc (ZYNE) Stock Price, Quote, latest community messages, chart, news and other stock related information. You can watch ZYNE and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling.
News for Zynerba Pharmaceuticals Stock (ZYNE) · Zynerba Pharmaceuticals Reports First Quarter Financial Results and Operational Highlights · Zynerba receives. Latest News. Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions. Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is at the forefront of developing next-generation synthetic cannabinoid therapeutics designed for transdermal. Notice: This company has been marked as potentially delisted and may not be actively trading. Add. Compare. Share. Share. Headlines. Stock Analysis. The latest Zynerba Pharmaceuticals stock prices, stock quotes, news, and ZYNE history to help you invest and trade smarter. Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for. ZYNE Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Earnings have grown % per year. News for Zynerba Pharmaceuticals Stock (ZYNE) ; Zynerba Pharmaceuticals (ZYNE) Stock Moves %: What You Should Know · 10/02/19 ; Zynerba Pharmaceuticals to. Zynerba Pharmaceuticals Inc is listed in the sector of the NASDAQ with ticker ZYNE. The last closing price for Zynerba Pharmaceuticals was $
The share price as of October 10, is / share. Previously, on September 6, , the share price was / share. This represents a decline of %. The share price of Zynerba Pharmaceuticals Inc as of October 10, is $ / share. The Factor Analysis chart (below right) shows a view. Zynerba Pharmaceuticals Inc is listed in the sector of the NASDAQ with ticker ZYNE. The last closing price for Zynerba Pharmaceuticals was $ Harmony Biosciences Holdings, Inc. entered into a definitive agreement to acquire Zynerba Pharmaceuticals, Inc.) for $ million. Track Zynerba Pharmaceuticals Inc (ZYNE) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Zynerba Pharmaceuticals develops synthetic cannabinoid based medicines to help treat a wide-range of needs. Currently, the company has a synthetic gel in phase. All information about Zynerba Pharmaceuticals (ZYNE) - stock price, quote chart, key statistics, dividends, company news and more. Zynerba Pharmaceuticals, Inc. · Legends: · % total return 09/ Stock. S&P 1Y. 3Y. 5Y. Technical analysis forecast of Zynerba Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock.
Fertility Finance Interest Rates | How To Lighten Dark Butt Crack